These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19164938)

  • 1. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
    Lyles BE; Akinyeke TO; Moss PE; Stewart LV
    Cell Cycle; 2009 Jan; 8(2):268-77. PubMed ID: 19164938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Moss PE; Lyles BE; Stewart LV
    Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
    Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC
    Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone.
    Zhao H; Gu H; Zhang H; Li JH; Zhao WE
    Biochim Biophys Acta; 2014 Jan; 1840(1):545-55. PubMed ID: 24036327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
    Zhang HL; Zhang ZX; Xu YJ
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):531-4. PubMed ID: 15555282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO; Stewart LV
    Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
    Higashi Y; Holder K; Delafontaine P
    J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
    Al-Alem L; Southard RC; Kilgore MW; Curry TE
    PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
    Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
    Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
    J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
    Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
    Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
    Chen HC; Hsu HT; Weng JW; Chang YF; Hsia CY; Lee HC; Chi CW
    J Chin Med Assoc; 2016 Aug; 79(8):415-21. PubMed ID: 27094504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
    Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
    World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells.
    Lau JY; Oliver BG; Moir LM; Black JL; Burgess JK
    Respirology; 2010 Feb; 15(2):303-12. PubMed ID: 20070588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.